Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

Alzheimer Disease Clinical Trial

Official title:

Evaluating the Effectiveness of Web-based Education Via Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior: A Randomized Trial

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03149380
• Other study ID #: 1311014539
• Status: Withdrawn
• Phase: N/A
• Start date: January 2017
• Est. completion date: October 2024

Study information

• Verified date: March 2023
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the effectiveness of an online educational course on Alzheimer's disease (AD) prevention, treatment and caregiving.

Description:

Alzheimer's Universe (www.AlzU.org) was created to provide online education about Alzheimer's disease (AD), with a focus on family members of people with AD, people with mild cognitive impairment due to AD and mild AD, caregivers, healthcare providers, medical students, college students and high school students. The website provides evidence-based courses with interactive lessons and activities that have been shown to increase knowledge about AD, willingness to participate in an AD prevention clinical trial, and intent to make specific lifestyle changes in effort to reduce AD risk.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: October 2024
• Est. primary completion date: December 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years and older

Eligibility

Inclusion Criteria:

• greater than or equal to 14 years old with a friend, family member or acquaintance with Alzheimer's disease or memory loss, OR a person diagnosed with mild memory loss (including mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease), OR an AD caregiver, OR healthcare providers, OR a medical student, college student or high school student.

Exclusion Criteria:

• < 14 years old, OR diagnosis of moderate or severe Alzheimer's disease

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer Disease, Late Onset
• Memory Disorders
• Memory Loss
• Patient Education as Topic

Intervention

Behavioral:
• Web-based education
The investigators will utilize interactive lessons and activities to educate about Alzheimer's disease prevention, treatment and caregiving, with focus on evidence-based lifestyle and nutritional recommendations that have been associated with delaying cognitive decline.

Locations

Country	Name	City	State
United States	Weill Medical College of Cornell University	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knowledge of AD Preventative behaviors	Knowledge is calculated as a positive change on multiple-choice questions about AD between pre vs. post-completion of educational material	12 months
Primary	Willingness to Engage in AD Preventative behaviors	Willingness is calculated as a positive change on questionnaires evaluating AD-preventative behaviors between pre vs. post-completion of educational material	12 months
Secondary	Participant Satisfaction	The investigators will assess general satisfaction with the educational modules via pre vs post-intervention participant surveys	12 months
Secondary	Behavioral Assessments	The investigators will evaluate related behavioral assessments via pre vs post-intervention participant surveys	12 months

External Links

•   Direct hyperlink to Alzheimer's Universe website